{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:09:07Z","timestamp":1764842947790,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bneo.2024.100055","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T07:08:01Z","timestamp":1730531281000},"page":"100055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL\/CTCL treatment: a multicenter phase 2 trial"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1646-813X","authenticated-orcid":false,"given":"Swaminathan P.","family":"Iyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaker","family":"Dakhil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-5330","authenticated-orcid":false,"given":"Michi M.","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4308-629X","authenticated-orcid":false,"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-3162","authenticated-orcid":false,"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Varghese","key":"10.1016\/j.bneo.2024.100055_bib1"},{"issue":"308","key":"10.1016\/j.bneo.2024.100055_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bneo.2024.100055_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hon.836","article-title":"Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review","volume":"26","author":"Rodriguez-Abreu","year":"2008","journal-title":"Hematol Oncol"},{"issue":"9","key":"10.1016\/j.bneo.2024.100055_bib5","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":"Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study","volume":"29","author":"O\u2019Connor","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100055_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","article-title":"Oral mucositis: the hidden side of cancer therapy","volume":"39","author":"Pulito","year":"2020","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.bneo.2024.100055_bib7","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1182\/blood.V118.21.4745.4745","article-title":"Efficacy of short oral leucovorin rescue (SOLR) in managing recurrent pralatrexate (Folotyn) induced mucositis (RPIM) despite dose reduction","volume":"118","author":"Haddad","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2024.100055_bib8","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3109\/10428194.2013.779688","article-title":"Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy","volume":"54","author":"Koch","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.bneo.2024.100055_bib9","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1080\/10428194.2019.1612061","article-title":"Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate","volume":"60","author":"Foss","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bneo.2024.100055_bib11","series-title":"WHO handbook for reporting results of cancer treatment","first-page":"15","article-title":"Toxic Effects","year":"1979"},{"issue":"14","key":"10.1016\/j.bneo.2024.100055_bib12","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1158\/1078-0432.CCR-10-0671","article-title":"Pralatrexate (PDX) is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies","volume":"16","author":"Marchi","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.bneo.2024.100055_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00280-014-2441-9","article-title":"Goldman ID the impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro","volume":"73","author":"Visentin","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.bneo.2024.100055_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00280-014-2580-z","article-title":"Leucovorin rescue allows effective high- dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts","volume":"74","author":"Tedeschi","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.bneo.2024.100055_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/bloodadvances.2023011095","article-title":"Pralatrexate injection combined with CHOP for treatment of PTCL: results from the Fol-CHOP dose-finding phase 1 trial","volume":"8","author":"Iyer","year":"2024","journal-title":"Blood Adv"},{"issue":"suppl 15","key":"10.1016\/j.bneo.2024.100055_bib16","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1200\/JCO.2016.34.15_suppl.7558","article-title":"Impact of leucovorin on mucositis and skin reactions in patients with PTCL and CTCL treated with pralatrexate","volume":"34","author":"Foss","year":"2016","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:57:33Z","timestamp":1762657053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2950328024000554"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100055","relation":{},"ISSN":["2950-3280"],"issn-type":[{"type":"print","value":"2950-3280"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL\/CTCL treatment: a multicenter phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100055"}}